Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance

被引：0
|
作者：
Onnekink, Anke M. [1 ,5 ]
Michiels, Nynke [2 ]
Klatte, Derk C. F. [1 ]
Oldenburg, Lotte [3 ]
Mieog, J. Sven D. [2 ]
Vahrmeijer, Alexander L. [2 ]
van Hooft, Jeanin E. [1 ]
van Leerdam, Monique E. [1 ,4 ]
Bonsing, Bert A. [2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[3] Locat Univ Amsterdam, Amsterdam UMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands
[5] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
INTERNATIONAL STUDY-GROUP; COMPLICATIONS; DEFINITION;
D O I：
10.1093/bjs/znad430
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
    S Jefferies
    S M Edwards
    R A Hamoudi
    R A’Hern
    W Foulkes
    D Goldgar
    R Eeles
    British Journal of Cancer, 2001, 85 : 1383 - 1386
  • [22] No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
    Jefferies, S
    Edwards, SM
    Hamoudi, RA
    A'Hern, R
    Foulkes, W
    Goldgar, D
    Collaborators, MPT
    Eeles, R
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1383 - 1386
  • [23] CDKN2A/p16 is inactivated by the combination of inversion and translocation
    Norris, Alexis L.
    Kamiyama, Hirohiko
    Hruban, Ralph H.
    Eshleman, James R.
    CANCER RESEARCH, 2015, 75
  • [24] Implications of P16/CDKN2A deletion in pleural mesotheliomas
    Ladanyi, M
    LUNG CANCER, 2005, 49 : S95 - S98
  • [25] Inactivation of CDKN2A gene (p16) in gallbladder carcinoma
    Roa, JC
    Vo, Q
    Araya, JC
    Villaseca, M
    Guzmán, P
    Ibacache, G
    de Aretxabala, X
    Roa, I
    REVISTA MEDICA DE CHILE, 2004, 132 (11) : 1369 - 1376
  • [26] Parental preferences for CDKN2A/p16 testing of minors
    Taber, Jennifer M.
    Aspinwall, Lisa G.
    Kohlmann, Wendy
    Dow, Reed
    Leachman, Sancy A.
    GENETICS IN MEDICINE, 2010, 12 (12) : 823 - 838
  • [27] Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer
    Astiazaran-Symonds, Esteban
    Graham, Cole
    Kim, Jung
    Tucker, Margaret A.
    Ingvar, Christian
    Helgadottir, Hildur
    Pastorino, Lorenza
    van Doorn, Remco
    Sampson, Joshua N.
    Zhu, Bin
    Bruno, William
    Queirolo, Paola
    Fornarini, Giuseppe
    Sciallero, Stefania
    Carter, Brian
    Hicks, Belynda
    Hutchinson, Amy
    Jones, Kristine
    Stewart, Douglas R.
    Chanock, Stephen J.
    Freedman, Neal D.
    Landi, Maria Teresa
    Hoiom, Veronica
    Puig, Susana
    Gruis, Nelleke
    Yang, Xiaohong R.
    Ghiorzo, Paola
    Goldstein, Alisa M.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [28] Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence
    Rodriguez, Sergio
    Bermudez, Litzy
    Gonzalez, Daniel
    Bernal, Camila
    Canas, Alejandra
    Henriquez, Berta
    Rojas, Adriana
    Morales-Ruiz, Teresa
    MOLECULAR MEDICINE REPORTS, 2022, 26 (05)
  • [29] Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
    Dacic, S.
    Popper, H. H.
    Kothmaier, H.
    Halbwedl, I.
    Morbini, P.
    Murer, B.
    Comin, C. E.
    Galateau-Salle, F.
    Demirag, F.
    Zeren, H.
    Attanoos, R.
    Gibbs, A.
    Cagle, P. T.
    LABORATORY INVESTIGATION, 2008, 88 : 339A - 340A
  • [30] CDKN2A/p16 is inactivated in most melanoma cell lines
    Castellano, M
    Pollock, PM
    Walters, MK
    Sparrow, LE
    Down, LM
    Gabrielli, BG
    Parsons, PG
    Hayward, NK
    CANCER RESEARCH, 1997, 57 (21) : 4868 - 4875
12345